approval
-
Merck receives European approval to expand use of Rebif
Merck announced that the European Commission (EC) has approved extension of the indication of Rebif (interferon beta-1a), its treatment for relapsing forms of multiple sclerosis (MS).
approval | 02 March 2012
-
ViroMed receives approval for Phase II trial in the US for diabetic peripheral neuropathy
ViroMed announced that VM202-DPN, the company's proprietary DNA medicine for treatment of diabetic peripheral neuropathy, has received approval from the US FDA for a Phase II clinical trial.
approval | 04 January 2012
-
Novartis receives approval in Japan for two innovative therapies
Approvals demonstrate ongoing Novartis commitment to bringing innovative treatments to patients in Japan.
approval | 27 September 2011
-
AstraZeneca announces first approval of FASLODEX in Japan
In Japan, it is estimated that annually 10,000 women with metastatic breast cancer will have their cancer recurring or progressing post endocrine therapy.
approval | 26 September 2011
-
Novartis drug Afinitor gains EU approval
Novartis announced that the European Commission has approved Afinitor (everolimus) tablets for the treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumors (NET) of pancreatic origin in adults with progressive…
approval | 05 September 2011
-
Abbott receives FDA approval for ALK gene test for lung cancer therapy selection
Abbott announced it has received approval from the US Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC). The new…
approval | 27 August 2011
-
Abbott receives FDA approval for Lupron Depot-PED for treatment of CPP
Two new strengths in a three-month formulation expand Lupron Depot-PED dosing options for children with CPP.
approval | 17 August 2011
-
Nutra Pharma receives regulatory approval to market Nyloxin in India
Nutra Pharma has received approval in India for its Nyloxin line of pain relievers.
approval | 11 August 2011
-
Watson's rosuvastatin zinc tablets receive tentative FDA approval
Watson Pharmaceuticals Inc announced that its subsidiary, Watson Laboratories Inc, has received tentative approval from the United States Food and Drug Administration (FDA) for its rosuvastatin zinc 5, 10, 20 and 40 mg tablets. Watson's rosuvastatin …
approval | 10 August 2011
-
Novartis receives approval in Japan for Onbrez inhalation capsules
Novartis announced that it has received regulatory approval in Japan for Onbrez inhalation capsules (indacaterol) 150 mcg once-daily for the treatment of chronic obstructive pulmonary disease (COPD). Onbrez is said to be the only once-daily COPD ther…
approval | 01 July 2011
